[1] 中华医学会.慢性乙型肝炎防治指南 (2010年版) [J].中国肝脏病杂志, 2011, 3 (1) :40-56.
|
[2]Lok AS, McMahon BJ.Chronic hepatitis B:update 2009[J].Hepatology, 2009, 50 (3) :661-662.
|
[3]Pawlotsky JM.EASL Clinical Practice Guidelines:management ofchronic hepatitis B[J].J Hepatol, 2009, 50 (2) :243-260.
|
[4]Karabay O, Tamer A, Tahtaci M, et al.Effectiveness of lamivudineand interferon-alpha combination therapy versus interferon-alphamonotherapy for the treatment of HBeAg-negative chronic hepatitis Bpatients:a randomized clinical trial[J].J Microbiol Immunol Infect, 2005, 38 (4) :262-266.
|
[5]Lampertico P, Vigano M, Manenti E, et al.Low resistance to adefo-vir combined with lamivudine:a 3-year study of 145 lamivudine-resistant hepatitis B patients[J].Gastroenterology, 2007, 133 (5) :1445-1451.
|
[6]慢性乙型肝炎联合抗病毒治疗专家共识委员会.慢性乙型肝炎联合抗病毒治疗专家共识[J].中华实验和临床感染病杂志 (电子版) , 2011, 5 (2) :224-233.
|
[7]Keeffe EB, Zeuzem S, Koff RS, et al.Report of an internationalworkshop:roadmap for management of patients receiving oral therapyfor chronic hepatitis B[J].Clin Gastroenterol Hepatol, 2007, 5 (8) :890-897.
|
[8]慢性丙型肝炎抗病毒治疗专家委员会.慢性丙型肝炎抗病毒治疗专家共识[J].中华实验和临床感染病杂志 (电子版) , 2009, 3 (1) :343-352.
|
[9]Wursthorn K, Jaroszewicz J, Zacher BJ, et al.Correlation betweenthe Elecsys HBsAg II assay and the Architect assay for the quantifi-cation of hepatitis B surface antigen (HBsAg) in the serum[J].JClin Virol, 2011, 50 (4) :292-296.
|
[10]Thompson AJ, Nguyen T, Iser D, et al.Serum hepatitis B surface anti-gen and hepatitis B e antigen titers:disease phase influences correlationwith viral load and intrahepatic hepatitis B virus markers[J].Hepatolo-gy, 2010, 51 (6) :1933-1944.
|
[1] | Infectious Diseases Physicians Branch, Chinese Medical Doctor Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus (version 2024)[J]. Journal of Clinical Hepatology, 2024, 40(8): 1557-1566. doi: 10.12449/JCH240809 |
[2] | Jianing KONG, Binbin ZHANG, Junping SHI. An excerpt of clinical practice guideline of prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (2024 edition)[J]. Journal of Clinical Hepatology, 2024, 40(9): 1767-1770. doi: 10.12449/JCH240908 |
[3] | Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2024 version)[J]. Journal of Clinical Hepatology, 2024, 40(12): 2371-2387. doi: 10.12449/JCH241206 |
[4] | Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. Journal of Clinical Hepatology, 2019, 35(1): 38-44. doi: 10.3969/j.issn.1001-5256.2019.01.007 |
[5] | Panel of Elastography Assessment of Liver Fibrosis, Study Group of Interventional Ultrasound, Society of Ultrasound in Medicine of Chinese Medical Association. Guidelines for clinical application of two-dimensional shear wave elastography in assessment of liver fibrosis in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(2): 255-261. doi: 10.3969/j.issn.1001-5256.2018.02.008 |
[6] | Dai MingJia, Leng XueJun, Yan XueBing. Interpretation of 2015 WHO guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection: comparison antiviral treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(7): 1004-1007. doi: 10.3969/j.issn.1001-5256.2015.07.003 |
[7] | Expert Committee for Antiviral Therapy for Special Patients with Chronic Hepatitis B;. Expert consensus on antiviral therapy for special patients with chronic hepatitis B: an update in 2015[J]. Journal of Clinical Hepatology, 2015, 31(8): 1185-1192. doi: 10.3969/j.issn.1001-5256.2015.08.002 |
[8] | Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association . The guideline of prevention and treatment for chronic hepatitis B: a 2015 update[J]. Journal of Clinical Hepatology, 2015, 31(12): 1941-1960. doi: 10.3969/j.issn.1001-5256.2015.12.002 |
[9] | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy (2015)[J]. Journal of Clinical Hepatology, 2015, 31(10): 1575-1578. doi: 10.3969/j.issn.1001-5256.2015.10.003 |
[10] | Chinese Society of Organ TransplantationChinese Medical Association;. Guidelines for application of tacrolimus in clinical liver transplantation[J]. Journal of Clinical Hepatology, 2015, 31(9): 1372-1374. doi: 10.3969/j.issn.1001-5256.2015.09.002 |
[11] | Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2015, 31(11): 1752-1769. doi: 10.3969/j.issn.1001-5256.2015.11.002 |
[12] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of chronic pancreatitis(2014)[J]. Journal of Clinical Hepatology, 2015, 31(3): 322-326. doi: 10.3969/j.issn.1001-5256.2015.03.002 |
[13] | Yan Jie, Xie Wen. Expert consenus on antiviral therapy for special patients with chronic hepatitis B: an update in 2014[J]. Journal of Clinical Hepatology, 2014, 30(7): 580-587. doi: 10.3969/j.issn.1001-5256.2014.07.002 |
[14] | Li XiaoQing, Qian JiaMing. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Updated June 2014[J]. Journal of Clinical Hepatology, 2014, 30(12): 1236-1239. doi: 10.3969/j.issn.1001-5256.2014.12.002 |
[15] | Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis ( Shanghai, 2013)[J]. Journal of Clinical Hepatology, 2013, 29(9): 656-660. doi: 10.3969/j.issn.1001-5256.2013.09.006 |
[16] | Yang Li, Lu LunGen. Introduction: EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection(2012)[J]. Journal of Clinical Hepatology, 2012, 28(6): 405-409. |
[17] | Liao YunFan, Jia-Horng Kao, Teerha Piratvisuth, et al. Asian-pacific consensus statement on the management of chronic hepatitis B: a 2012 update[J]. Journal of Clinical Hepatology, 2012, 28(8): 641-661. |
[18] | Fan Rong, Liang XieEr, Sun Jian, Hou JinLin. Explanation of the “Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update”: Treatment strategy, resistance management and non-invasive evalution of liver fibrosis[J]. Journal of Clinical Hepatology, 2012, 28(7): 484-486. |
[19] | Li Hai, Jia JiDong. Interpretation of the guideline on prevention and treatment for chronic hepatitis B (2010 version) -the goals and indications for chronic hepatitis B treatment[J]. Journal of Clinical Hepatology, 2011, 27(8): 791-793. |
[20] | Jia JiDong, Li LanJuan. The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J]. Journal of Clinical Hepatology, 2011, 27(1): 113-128. |